Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Journal of Pharmaceutical and Biomedical Analysis|September 7, 2015
A multi-targeted liquid chromatography-mass spectrometry screening procedure for the detection in human urine of drugs non-prohibited in sport commonly used by the athletesMonica Mazzarino, Lorenzo Cesarei, Xavier de la Torre, et al.
Analytical and Bioanalytical Chemistry|March 10, 2026
Simple and sensitive cellulose paper-based microextraction of 25 steroid esters from human serum/plasma for doping control purposesMonica Mazzarino, Wim Van Gansbeke, Aðalheiður Dóra Albertsdóttir, et al.
Forensic Toxicology|November 22, 2024
Metabolic profiling of the synthetic cannabinoid APP-CHMINACA (PX-3) as studied by in vitro and in vivo modelsCristian Camuto, Fabio De-Giorgio, Giorgia Corli, et al.
ACS Omega|September 19, 2022
UHPLC-HRMS Method for the Simultaneous Screening of 235 Drugs in Capillary Blood for Doping Control Purpose: Comparative Evaluation of Volumetric and Non-volumetric Dried Blood Spotting DevicesMonica Mazzarino, Ludovica Di Costanzo, Fabio Comunità, et al.
Talanta|June 3, 2026
Analytical validation of a dried blood microsampling method to measure androstenedione, 17α‑hydroxyprogesterone, and 11‑ketotestosterone for congenital adrenal hyperplasia monitoringHanna De Baets, Tim Reyns, Monica Mazzarino, et al.
Rapid Communications in Mass Spectrometry : RCM|February 27, 2010
Mass spectrometric characterization of tamoxifene metabolites in human urine utilizing different scan parameters on liquid chromatography/tandem mass spectrometryMonica Mazzarino, Xavier de la Torre, Roberto Di Santo, et al.
Drug Testing and Analysis|August 3, 2022
Urinary excretion profile of prednisolone and prednisone after rectal administration: Significance in antidoping analysisLoredana Iannella, Fabio Comunità, Francesco Botrè, et al.
Drug Testing and Analysis|June 13, 2020
Carbon isotopic characterization of prednisolone and prednisone pharmaceutical formulations: Implications in antidoping analysisLoredana Iannella, Francesco Botrè, Cristiana Colamonici, et al.
Journal of Pharmaceutical and Biomedical Analysis|August 1, 2017
Characterization of the phase I and phase II metabolic profile of tolvaptan by in vitro studies and liquid chromatography-mass spectrometry profiling: Relevance to doping control analysisMonica Mazzarino, Valeria Buccilli, Xavier de la Torre, et al.
Drug Testing and Analysis|July 18, 2020
Urinary excretion profile of methiopropamine in mice following intraperitoneal administration: A liquid chromatography-tandem mass spectrometry investigationCristian Camuto, Sheila Pellegrini, Fabio De-Giorgio, et al.
Pageof 7